Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2026)

Indivior Pharmaceuticals' FCF Margin history runs 3 years deep, the most recent figure standing at 9.15% for Q1 2026.

• In Q1 2026, FCF Margin fell 3546.0% year-over-year to 9.15%; the TTM figure through Mar 2026 stood at 14.87% (down 2478.0% YoY), while the FY2025 annual figure was 7.51%, down 810.0% from the prior year.
• FCF Margin was 9.15% for Q1 2026 at Indivior Pharmaceuticals, up from 68.44% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 46.69% in Q2 2025 to a low of 68.44% in Q4 2025.
• Historically, FCF Margin has averaged 2.41% across 3 years, with a median of 9.15% in 2026.
• Biggest YoY gain for FCF Margin was 4005 bps in 2025; the steepest drop was 5740 bps in 2025.
• A 3-year view of FCF Margin shows it stood at 11.04% in 2024, then sank by 520 bps to 68.44% in 2025, then soared by 87 bps to 9.15% in 2026.
• The last three FCF Margin figures came in at 9.15% (Q1 2026), 68.44% (Q4 2025), and 18.79% (Q3 2025), per Business Quant data.